Key result
No clinical data found in the provided text, which is a software manual for Open Journal Systems.
Why the study?
Poor adherence worsens chronic heart failure manifestations and hospitalizations, prompting the study to characterize quality of life and evaluate the effect of medication adherence in elderly patients with HFpEF, arterial hypertension, and chronic kidney disease.
Does medication adherence improve quality of life in patients with chronic heart failure with preserved ejection fraction, arterial hypertension, and chronic kidney disease?
Population
122 patients aged 64 [62; 68] years with chronic heart failure, arterial hypertension, and chronic kidney disease
Comparison
Adherent cohort vs non-adherent cohort based on medication adherence level
Design
Prospective study
Follow-up
12 months
Authors
Loading...
Non-adherence linked to worse QoL in HFpEF with hypertension and CKD; hypothesis-generating and requires randomized trials before informing care.
Does medication adherence improve quality of life in patients with chronic heart failure with preserved ejection fraction, arterial hypertension, and chronic kidney disease?
Poor medication adherence in patients with HFpEF, hypertension, and chronic kidney disease is associated with worse disease compensation and significantly deteriorated quality of life up to 12 months.
Ханюков et al. (2021) studied this question. No clinical data found in the provided text, which is a software manual for Open Journal Systems.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: